News
10h
Stocktwits on MSNSoleno Launches Pill For Hyperphagia In Prader-Willi Syndrome Patients But Retail’s UnmovedShares of biopharmaceutical company Soleno Therapeutics, Inc. (SLNO) were in the spotlight on Monday after the company ...
In the study, 320 men between ages 45–75 saw a significant reduction in nocturia, inflammation, and urinary urgency over a 24 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results